epigenetic therapy

CAMBRIDGE, Mass., July 17, 2026 Anova and Nouveau Biosciences announced a strategic partnership to conduct clinical development of Kromastat...

SAN FRANCISCO, Calif., June 26, 2026 Epicrispr Biotechnologies announced encouraging interim Phase 1/2 clinical trial results for EPI-321, its...

San Rafael, California, United States | May 2, 2026 BioMarin Pharmaceutical Inc. has presented new long-term clinical data for...

Alameda, California, United States | April 30, 2026 Scribe Therapeutics has announced significant advancements in its engineered CRISPR gene...

San Diego, USA & Suzhou, China, April 2, 2026 Strong Clinical Efficacy in MSS Colorectal Cancer In a major...

South San Francisco, California, USA, April 6, 2026 First-in-Class Epigenetic Therapy Enters Clinical Development In a major step forward...